Trials / Sponsors / Danatlas Pharmaceuticals Co., Ltd
Danatlas Pharmaceuticals Co., Ltd
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in A Advanced Solid Tumors | Phase 1 | 2025-07-31 |
| Not Yet Recruiting | A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss Solid Cancers, BRCA Mutation, HRD Cancer | Phase 1 | 2024-11-01 |